Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0W1PF
|
||||
| Former ID |
DNC007133
|
||||
| Drug Name |
LUF-5980
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528673] | ||
| Formula |
C21H19N3
|
||||
| Canonical SMILES |
CC(C)C1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4
|
||||
| InChI |
1S/C21H19N3/c1-14(2)20-23-19-17(15-9-5-3-6-10-15)13-18(22-21(19)24-20)16-11-7-4-8-12-16/h3-14H,1-2H3,(H,22,23,24)
|
||||
| InChIKey |
REXYMDQLBZWOMA-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [528673] | |
| Adenosine A1 receptor | Target Info | Inhibitor | [528673] | ||
| Adenosine A2b receptor | Target Info | Inhibitor | [528673] | ||
| Adenosine A2a receptor | Target Info | Inhibitor | [528673] | ||
| KEGG Pathway | cGMP-PKG signaling pathway | ||||
| cAMP signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Morphine addictionhsa04015:Rap1 signaling pathway | |||||
| Calcium signaling pathway | |||||
| Vascular smooth muscle contraction | |||||
| Alcoholismhsa04015:Rap1 signaling pathway | |||||
| Parkinson's disease | |||||
| Alcoholism | |||||
| Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.